August 1, 2024

Nonclinical Solutions - Toxicology

Propel your development program with Labcorp's comprehensive toxicology solutions. Toxicology plays a critical role in assessing and mitigating potential adverse effects, ensuring regulatory compliance, and understanding toxicity mechanisms to optimize drug safety and efficacy. To enhance the therapeutic potential of your drug candidate while minimizing patient risk, partnering with a laboratory that offers extensive capabilities and expertise is essential.
<span>Three best practices to cultivate healthier, thriving communities</span>
August 26, 2024

Three best practices to cultivate healthier, thriving communities

Managed care organizations are no strangers to alarming statistics about barriers to healthcare access. Nevertheless, the numbers are still astounding when laid out next to each other—especially for those residing in the rural United States. We can help cultivate healthier, thriving communities with the best practices below.

Gilles Baud, PhD

Dr. Gilles Baud joined Labcorp Biopharma Laboratory Services in 2023, working on the validation of performances of molecular biology assays, ranging from qPCRs to NGS, for the department of genomics.

Gilles received his PhD from the University of Lausanne, where he worked at the interface among molecular biology, bioinformatics and microbiology.

Magali Dupont, PhD

Dr. Magali Dupont joined Labcorp in July 2021. In her role, she oversees new immunoassays and new platforms validation work performed at the central laboratory in Geneva, Switzerland. She finds solutions to scientific operational challenges and client questions, while investigating new biomarkers and methodologies to foster high-quality scientific delivery.

Trinidad Martín Campos, PhD

Dr. Trinidad Martín Campos conducts analysis support for Labcorp’s Genomics department, driving data analysis and pipeline development for a wide variety of assays, from qPCR- and array-based platforms to a full spectrum of next-generation sequencing assays. She is also the bioinformatician contact for PGDx in Europe, a complete test that enables rapid and actionable genomic insight for patients with advanced cancer.

Anthony Guihur, PhD

Dr. Anthony Guihur brings extensive experience in molecular biology, biochemistry, and “omics” (genomics, transcriptomics, proteomics) with a touch of bioinformatics and data analysis. He earned his PhD from the University of Tours in France where he specialized in plant secondary metabolism (terpene biosynthesis). He then held a postdoctoral position at the University of Lausanne in Switzerland, studying heat shock proteins in plants and other organisms.

Cell and Gene Therapy Answers: The critical role of flow cytometry in adoptive cell therapies

Adoptive cell therapy (ACT) is a promising type of immunotherapy that involves engineering a patient's immune cells to recognize and attack their cancer. As this field continues to grow, researchers are focused on refining the process to make ACT more effective in supporting the patient immune response. One critical tool for developing better ACT treatments is flow cytometry. To learn more about how flow cytometry enables advances in ACTs, we spoke with Leanne Flye, associate director of scientific operations, general laboratory, at Labcorp.

<span>Cell and Gene Therapy Answers: The critical role of flow cytometry in adoptive cell therapies</span>
August 20, 2024

Cell and Gene Therapy Answers: The critical role of flow cytometry in adoptive cell therapies

Adoptive cell therapy (ACT) is a promising type of immunotherapy that involves engineering a patient's immune cells to recognize and attack their cancer. As this field continues to grow, researchers are focused on refining the process to make ACT more effective in supporting the patient immune response. One critical tool for developing better ACT treatments is flow cytometry. To learn more about how flow cytometry enables advances in ACTs, we spoke with Leanne Flye, associate director of scientific operations, general laboratory, at Labcorp.